Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Management

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • Management
  • News

Simpson Announces CEO Retirement And Succession Plan

By Benzinga Newsdesk
September 8, 4:10 PM
Karen Colonias to step down as CEO on December 31, 2022, and retire from the Company on June 30, 2023 Michael Olosky to succeed Karen Colonias as Chief Executive Officer on January

SSD

Read More
2 minute read
  • Cannabis
  • Global
  • Management
  • Markets
  • News
  • Penny Stocks
  • Psychedelics

Canadian Psychedelics Company To Begin First Global DMT Clinical Trial For Stroke Treatment

By Lara Goldstein
September 8, 3:57 PM
Algernon Pharmaceuticals Inc. (OTCQB: AGNPF) has set up a clinical research program for the treatment of strokes, focused on its proprietary DMT analogue, AP-188. The company is also planning to begin a Phase 1 clinical trial in 2022’s fourth quarter.

AGNPF

Read More
2 minute read
  • Emerging Markets
  • ETFs
  • Fintech
  • Management
  • Markets
  • News

Cathie Wood’s Successor? This Guy May Just Be The Next To Lead Ark Invest — Here’s How He Thinks

By AJ Fabino
September 8, 2:56 PM
The Cathie Wood-led and closely followed Ark Invest fund is doubling down on the overarching idea that emerging innovation platforms will radically transform the global economy by creating a new chief futurist role.

ARKK

Read More
1 minute read
  • Management
  • News
  • Penny Stocks

Yatra Online Appoints Rohan Mittal As Finance Chief

By Shivani Kumaresan
September 8, 2:41 PM
Travel services provider Yatra Online Inc (NASDAQ:YTRA) has appointed Rohan Mittal as Group Chief Financial Officer (CFO) effective September 8. Mittal brings…

YTRA

Read More
1 minute read
  • Management
  • News
  • Tech

Shopify Ropes In Morgan Stanley Veteran Jeff Hoffmeister As Finance Chief

By Anusuya Lahiri
September 8, 12:47 PM
Shopify Inc (NYSE: SHOP) announced critical leadership changes. It appointed Jeff Hoffmeister as the CFO. Hoffmeister succeeds Amy Shapero, who stepped down…

MS

Read More
3 minute read
  • Management
  • News

ReWalk Robotics Appoints Michael Lawless As CFO Effective September 19

By Benzinga Newsdesk
September 8, 8:31 AM
 

RWLK

Read More
4 minute read
  • Management
  • News

Shopify Announces Leadership Changes Kaz Nejatian Promoted to COO Succeeding Toby Shannan; Jeff Hoffmeister Appointed CEO Succeeding Amy Shapero

By Benzinga Newsdesk
September 8, 8:16 AM
Shopify Announces Leadership Changes Kaz Nejatian Promoted to Chief Operating Officer Succeeding Toby Shannan, Who Will Transition to Special Advisor and Board Member Jeff Hoffmeister Appointed Chief Financial Officer

SHOP

Read More
2 minute read
  • Cannabis
  • Global
  • Management
  • Markets
  • News
  • Psychedelics

Intradermal Ketamine Patch Completes Pre-Clinical Phase, Advances To Clinical Studies

By Lara Goldstein
September 7, 6:29 PM
PharmaTher Holdings (OTCQB: PHRRF), the biopharma company developing novel uses and delivery forms of ketamine for mental health treatments, has completed an IND-enabling pharmacokinetic and tolerability study of its ketamine patch, KETARX, in minipigs. 

PHRRF

Read More
1 minute read
  • Management
  • Movers
  • News
  • Trading Ideas

Why Is Target Stock Trading Higher?

By Adam Eckert
September 7, 3:37 PM
Target Corp (NYSE: TGT) shares are trading higher Wednesday alongside several retailers amid overall market strength as stocks rebound from recent weakness. Target also announced leadership changes Wednesday morning.

TGT

Read More
1 minute read
  • Guidance
  • Management
  • Movers
  • News
  • Small Cap
  • Trading Ideas

Freshpet Finance Chief Steps Down; Co. Reaffirms FY22 Outlook

By Shivani Kumaresan
September 7, 12:05 PM
Freshpet Inc (NASDAQ:FRPT) said its Chief Financial Officer Heather Pomerantz has decided to step down to pursue other opportunities effective September…

FRPT

Posts pagination

Previous 1 … 321 322 323 … 341 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service